RAHWAY, N.J. & SAN DIEGO--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Prometheus Biosciences, Inc. (“Prometheus”) (Nasdaq: RXDX) today announced that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results